Skip to main content
Top
Published in: Journal of Translational Medicine 1/2010

Open Access 01-12-2010 | Research

Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1

Authors: Elisabetta Ricci, Sandro Malacrida, Marisa Zanchetta, Ilaria Mosconi, Marco Montagna, Carlo Giaquinto, Anita De Rossi

Published in: Journal of Translational Medicine | Issue 1/2010

Login to get access

Abstract

Background

Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns and play a crucial role in the host's innate immune response. Genetic variations in TLR genes may influence host-viral interactions and might impact upon the risk of mother-to-child transmission (MTCT) of Human Immunodeficiency Virus type 1 (HIV-1). The aim of this study was to investigate the influence of genetic variants of TLR 9 gene on MTCT.

Methods

Three hundred children (118 HIV-1-infected and 182 HIV-1-uninfected) born to HIV-1-infected mothers were studied. Single nucleotide polymorphisms (SNPs) NM_017442.2: c.4-44G > A (rs352139) and c.1635A > G (rs352140) of the TLR9 gene were genotyped by TaqMan allelic discrimination assay. Statistical analyses were performed using SNPStats program.

Results

When considered separately, neither of the two SNPs was significantly associated with risk of HIV-1 infection. However, the [A;A] and [G;G] haplotypes were associated with a higher risk of HIV-1 infection compared to the prevalent [G;A] haplotype [odds ratio (OR) = 3.16, 95% confidence interval (CI) 1.24-8.03, p = 0.016, and OR = 5.54, 95% CI 1.76-17.50, p = 0.004, respectively].

Conclusions

Overall, results demonstrate a significant correlation between specific genetic variants of the TLR9 gene and risk of MTCT of HIV-1, thus confirming a critical role of innate immunity in perinatal HIV-1 infection. Strategies aimed at modulating innate immunity might be useful for future treatment of pediatric HIV-1 infection and AIDS.
Literature
1.
go back to reference The European Collaborative Study:: Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS. 1999, 13: 1377-1385. 10.1097/00002030-199907300-00016.CrossRef The European Collaborative Study:: Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS. 1999, 13: 1377-1385. 10.1097/00002030-199907300-00016.CrossRef
2.
go back to reference Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.PubMedCrossRef Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.PubMedCrossRef
3.
go back to reference Uematsu S, Akira S: Toll-like receptors and innate immunity. J Mol Med. 2006, 84: 712-725. 10.1007/s00109-006-0084-y.PubMedCrossRef Uematsu S, Akira S: Toll-like receptors and innate immunity. J Mol Med. 2006, 84: 712-725. 10.1007/s00109-006-0084-y.PubMedCrossRef
4.
go back to reference Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, van der Ven van der AJ: The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS. 2007, 21: 1375-1377. 10.1097/QAD.0b013e32814e6b2d.PubMedCrossRef Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, van der Ven van der AJ: The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS. 2007, 21: 1375-1377. 10.1097/QAD.0b013e32814e6b2d.PubMedCrossRef
5.
go back to reference Oh DY, Taube S, Hamouda O, Kücherer C, Poggensee G, Jessen H, Eckert JK, Neumann K, Storek A, Pouliot M, Borgeat P, Oh N, Schreier E, Pruss A, Hattermann K, Schumann RR: A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis. 2008, 198: 701-709. 10.1086/590431.PubMedCrossRef Oh DY, Taube S, Hamouda O, Kücherer C, Poggensee G, Jessen H, Eckert JK, Neumann K, Storek A, Pouliot M, Borgeat P, Oh N, Schreier E, Pruss A, Hattermann K, Schumann RR: A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis. 2008, 198: 701-709. 10.1086/590431.PubMedCrossRef
6.
go back to reference Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A, Swiss HIV Cohort Study: Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS. 2007, 21: 441-446. 10.1097/QAD.0b013e328012b8ac.PubMedCrossRef Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A, Swiss HIV Cohort Study: Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS. 2007, 21: 441-446. 10.1097/QAD.0b013e328012b8ac.PubMedCrossRef
7.
go back to reference Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, Rodríguez Mdel M, Salinas A, Pulido I, Sáez ME, Leal M: Influence of the Toll-like receptor 9 1635A/G polymorphism on CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr. 2008, 49: 128-135. 10.1097/QAI.0b013e318184fb41.PubMedCrossRef Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, Rodríguez Mdel M, Salinas A, Pulido I, Sáez ME, Leal M: Influence of the Toll-like receptor 9 1635A/G polymorphism on CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr. 2008, 49: 128-135. 10.1097/QAI.0b013e318184fb41.PubMedCrossRef
8.
go back to reference Pine SO, McElrath MJ, Bochud PY: Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS. 2009, 27: 2387-95. 10.1097/QAD.0b013e328330b489.CrossRef Pine SO, McElrath MJ, Bochud PY: Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS. 2009, 27: 2387-95. 10.1097/QAD.0b013e328330b489.CrossRef
9.
go back to reference Barton GM, Kagan JC, Medzhitov R: Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2006, 7: 49-56. 10.1038/ni1280.PubMedCrossRef Barton GM, Kagan JC, Medzhitov R: Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2006, 7: 49-56. 10.1038/ni1280.PubMedCrossRef
10.
go back to reference De Rossi A, Ades AE, Mammano F, Del Mistro A, Amadori A, Giaquinto C, Chieco-Bianchi L: Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS. 1991, 5: 15-20. 10.1097/00002030-199101000-00002.PubMedCrossRef De Rossi A, Ades AE, Mammano F, Del Mistro A, Amadori A, Giaquinto C, Chieco-Bianchi L: Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS. 1991, 5: 15-20. 10.1097/00002030-199101000-00002.PubMedCrossRef
11.
go back to reference Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A: Role of β-Defensin-1 polymorphisms in mother-to-child transmission of Human Immunodeficiency Virus Type 1. J Acquir Immune Defic Syndr. 2009, 51: 13-19. 10.1097/QAI.0b013e31819df249.PubMedCrossRef Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A: Role of β-Defensin-1 polymorphisms in mother-to-child transmission of Human Immunodeficiency Virus Type 1. J Acquir Immune Defic Syndr. 2009, 51: 13-19. 10.1097/QAI.0b013e31819df249.PubMedCrossRef
12.
go back to reference Solé X, Guinó E, Valls J, Iniesta R, Moreno : SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006, 22: 1928-1929. 10.1093/bioinformatics/btl268.PubMedCrossRef Solé X, Guinó E, Valls J, Iniesta R, Moreno : SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006, 22: 1928-1929. 10.1093/bioinformatics/btl268.PubMedCrossRef
13.
go back to reference Jamieson DJ, Clark J, Kourtis AP, Taylor AW, Lampe MA, Fowler MG, Mofenson LM: Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol. 2007, 197: S26-32. 10.1016/j.ajog.2007.03.087.PubMedCrossRef Jamieson DJ, Clark J, Kourtis AP, Taylor AW, Lampe MA, Fowler MG, Mofenson LM: Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol. 2007, 197: S26-32. 10.1016/j.ajog.2007.03.087.PubMedCrossRef
14.
go back to reference Bowie AG, Haga IR: The role of Toll-like receptors in the host response to viruses. Mol Immunol. 2005, 42: 859-867. 10.1016/j.molimm.2004.11.007.PubMedCrossRef Bowie AG, Haga IR: The role of Toll-like receptors in the host response to viruses. Mol Immunol. 2005, 42: 859-867. 10.1016/j.molimm.2004.11.007.PubMedCrossRef
15.
go back to reference Müller T, Hamm S, Bauer S: TLR9-mediated recognition of DNA. Handb Exp Pharmacol. 2008, 183: 51-70. full_text.PubMedCrossRef Müller T, Hamm S, Bauer S: TLR9-mediated recognition of DNA. Handb Exp Pharmacol. 2008, 183: 51-70. full_text.PubMedCrossRef
16.
go back to reference Carpenter EL, Mick R, Rüter J, Vonderheide RH: Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation. J Transl Med. 2009, 7: 93-10.1186/1479-5876-7-93.PubMedPubMedCentralCrossRef Carpenter EL, Mick R, Rüter J, Vonderheide RH: Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation. J Transl Med. 2009, 7: 93-10.1186/1479-5876-7-93.PubMedPubMedCentralCrossRef
17.
go back to reference Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, Yasutomo K: Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007, 66: 905-909. 10.1136/ard.2006.065961.PubMedPubMedCentralCrossRef Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, Yasutomo K: Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007, 66: 905-909. 10.1136/ard.2006.065961.PubMedPubMedCentralCrossRef
18.
go back to reference Leoratti FM, Farias L, Alves FP: Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J Infect Dis. 2008, 198: 772-780. 10.1086/590440.PubMedCrossRef Leoratti FM, Farias L, Alves FP: Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J Infect Dis. 2008, 198: 772-780. 10.1086/590440.PubMedCrossRef
19.
go back to reference Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB: Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med. 2008, 14: 1077-1087. 10.1038/nm.1871.PubMedCrossRef Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB: Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med. 2008, 14: 1077-1087. 10.1038/nm.1871.PubMedCrossRef
Metadata
Title
Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1
Authors
Elisabetta Ricci
Sandro Malacrida
Marisa Zanchetta
Ilaria Mosconi
Marco Montagna
Carlo Giaquinto
Anita De Rossi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2010
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-8-49

Other articles of this Issue 1/2010

Journal of Translational Medicine 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.